"Willingness to accept collateral damage may seem chilling, but it 
has some historical precedent.  The path of medical progress is 
strewn with cases of questionable ethics, desperate practices, and 
misguided experimentalism, if not outright exploitation.  And since 
patients with the fewest options are invariable the ones most likely 
to try (or be forcibly volunteered for) risky new treatments ... 
they're also the ones who bear the brunt of medicine's experimental nature.

"As many as half of all clinical trials are already conducted in 
locations far from the pharmaceutical companies' home base, in 
countries like India, China, and Brazil.  ... Drug outsourcing is 
seen as the fast to economic and scientific growth - a money train 
that the country [India] can't afford to miss. ...  India, the 
brilliant hub of outsourced labor, was positioning itself in a newly 
lucrative role - guinea pig to the world."

Wired, 03/2006, p 145 ff


"People Who experience mood swings, fear, voices and visions"